Conversely, in tumors where Rab25 drives upregulation of CLIC3, lysosomally routed active integrins will be returned to the plasma membrane, thus avoiding degradation and enabling their continued signaling to drive tumor progression. Here, CLIC3 is linked to neoplasm.